Thus peripheral erythrocytes incorporate 5-methyltetrahydrofolate by a saturable, temperature-dependent, substrate-specific process which is influenced by counter-transport. This mechanism is qualitatively similar to the carrier-mediated transport of folate compounds previously described in other cell types. Therefore, human erythrocytes should be useful for detailed characterization of this membrane carrier system.
INTRODUCTION
Mammalian cells incorporate folate compounds by specific transport mechanisms. 5-methyltetrahydrofolate (5-CH3-H4-folate),1 5-formyltetrahydrofolate (5-CHO-H4-folate), and methotrexate (Mtx) apparently share one membrane carrier system, whereas the oxidized form of the vitamin, pteroylglutamic acid (PGA), is probably transported by a second carrier (1) . Although 5-CH3-H4-folate transport has been well characterized in a number of experimental systems, relatively little is known about its uptake by human cells. Previous studies of human bone marrow cells (2) and of mitogen-stimulated lymphocytes (1, 3) suggest that these cells incorporate 5-CH3-H4-folate by processes similar to those in nonhuman cells, but such studies have been limited by difficulty in obtaining large numbers of cells for detailed characterization. Folate transport in mature human erythrocytes has not been extensively studied. We present evidence that mature erythrocytes transport-5-CH3-H4-folate by a carrier-mediated process similar to that found for folate and folate analogues in other normal and neoplastic cells (3) (4) (5) (6) (7) (8) .
METHODS
Subjects. Studies were performed with peripheral erythrocytes from normal volunteers, from patients with idiopathic aplastic anemia or chemotherapy-(Daunomycin-cytosine arabinoside) induced aplasia, and from patients with Coombs positive hemolytic anemia. Samples were obtained with the informed consent of the subjects.
Erythrocyte preparation. Heparinized (beeflung heparin, Upjohn Co., Kalamazoo, Mich.) peripheral blood was washed three times with phosphate-buffered saline (PBS) containing 5 mM phosphate, pH 7.2. In preliminary experiments, this concentration of phosphate did not decrease folate uptake compared to saline alone. The cells were resuspended in PBS I Abbreviatiotns ised in this paper: 5-CH3-H4-folate, 5-methyltetrahydrofolate; 5-CHO-H4-folate, 5-formyltetrahydrofolate; Mtx, methotrexate; PGA, pteroylglutamic acid; F/CN, sodium fluoride/sodium cyanide; PBS, phosphate-buffered saline; To, time zero. to a hematocrit of' 50. In some experimiienits, leukocytes and platelets were removed by bead defibrination, Ficoll-Hvpa(lue gradient, or sedimentation with 3% dextran for 1 h.
Erythrocyte, leukocyte, and platelet counts were done wvith a Coulter Z; reticulocyte percentage was deterInined by standard procedures. The erythrocyte suspenision was divided into 1-ml aliquots, and isotope added in 0. (11) . Membrane-free hemolysate was fractionated on A-25 DEAE-Sephadex by the method previously cited (9) . A 0.9 x 27-cm column was eqtuilibrated with 0.1 M phosphate buffer, pH 6, containing 0.2 M mercaptoethanol. Sample and marker compounds (p-aminobenzoylglutamate, 5-CHO-H4-folate, and tetrahydrofolate) were applied; 40 ml of starting buffer was followed by a gradient from 250-ml volumes of 0. 1-M and 0.8-M phosphate buffers. 4.4-ml fractions were collected.
Counter transport. Erythrocytes were incubated for 1 h at 37°C in a shaker bath with either 60 ,1M 5-CHO-H4-folate in 20 mM ascorbate-saline or ascorbate-saline alone. (Fig. 3) .
Inhibition by other folate compounds. Erythrocytes were incubated for 90 min with 2 uM [14C]5-CH3-H4-folate and increasing concentrations of unlabeled folate compounds. Mtx and reduced folates (5-CH3-H4-folate and 5-CHO-H4-folate) effectively inhibited [14C]5-CH3-H4-folate uptake whereas inhibition by PGA was only partial (Fig. 4) (Fig. 5) .
Counter-transport. Uptake of [14C]5-CH3-H4-folate was enhanced in cells previously incubated with 5-CHO-H4-folate, and efflux of radioactivity was greatly increased by extracellular 5-CHO-H4-folate (Fig. 6) erythrocytes by this method is 3.79+0.70 ,M/g hemoglobin) whereas incubation with F/CN almost totally depleted ATP (0.28+0.14 uM/g hemoglobin).
When energy-replete and -depleted cells were incubated for 90 min at 37°C with increasing concentrations of [14C]5-CH3-H4-folate, uptake was consistently higher in the ATP-depleted cells at all concentrations tested. Statistical analysis with the paired t test (16) showed this difference was significant for all concentrations tested (P < 0.01 for 0.2 AM [14C]5-CH3-H4-folate or higher; P < 0.05 for lower concentrations). The kinetic curve resembled that of control cells in that both deviated from linearity, consistent with saturation (Fig. 7) . A double-reciprocal plot of this data (15) fered significantly in the tNwo groups wheni tested b1 the paired t test (16) . The observed ef'fltux rate conlstants±41 SD for control cells \was 0.036±+(0.003 pmol/ 109 cells per min; for F/CN-treated cells was 0.031 ±0.008 pmol/109 cells per min (Fig. 8) .
DISCUSSION
These studies indicate that human peripheral erythrocytes transport, but do not metabolize, 5-CH3-H4-folate under the conditions of these experiments, and that uptake represents membrane transport function independent of intracellular folate metabolism. Uptake of 5-CH3-H4-folate was by erythrocytes, rather than other formed elements, because uptake did not change after addition or depletion of leukocytes and platelets, and was nearly identical in erythrocytes from normal individuals and in cells from patients with profound leukopenia, reticulocytopenia, and thrombocytopenia. Although the possibility must be considered that the observed uptake is the result of the few remaining reticulocytes (4, 17) , extrapolation of the linear relationship between uptake and reticulocyte count to zero reticulocytes predicts an uptake by mature erythrocytes comparable to our measured values. Thus, uptake in these studies is probably not significantly influenced by the small number of reticulocytes present.
The mechanism of erythrocyte folate uptake appears to involve a membrane-carrier system, because uptake is saturable, temperature dependent, substrate specific, and influenced by counter transport (18) . Like the carrier systems previously described in L-1210 leukemia cells (8, 19) and in stimulated lymphocytes (3) , this transport system has markedly different relative affinities for folate compounds, consistent with the presence of two carrier systems in erythrocytes as well, one specific for reduced folates and Mtx, and a second for PGA (1) . These differences in carrier affinity for folate analogues are also consistent with prior observations that there is no measurable increase of erythrocyte folate after injection of PGA or [3H]PGA into animals or man (20, 21) , and that incubation of erythrocytes with [3H]-PGA in vitro results in only low levels of uptake (17) , whereas there is significant erythrocyte incorporation of [14C]5-CH3-H4-folate in vitro (22) . The affinity of the erythrocyte transport system for 5-CH3-H4-folate approximates that reported in other experimental systems; our observed Km of 0.6 ,uM is comparable to K,'s of 1 4M in L-1210 leukemia cells (19) , 0.9 ,M in hog choroid plexus (6) , and 0.9 ,uM in Lactobacillus casei (23) . This Km for erythrocytes must be considered at present to be only an approximation, however, because the stereospecificity of the transport mechanism is unknown. The radioisotope used in these experiments was a mixture of D and L stereoisomers. If only the biologically active form (+) L-CH3-H4-folate is transported, the true Km may be lower than our measured value.
Although these characteristics of the folate uptake system in erythrocytes, consistent with a carrier system, are similar to those in other experimental systems (3, 19, 24) , human erythrocytes appear to incorporate less 5-CH3-H4-folate during incubations with the vitamin than do reticulocytes, bone marrow cells (2), or stimulated lymphocytes (1, 3) . This quantitative difference may result from loss, with maturation, of transport systems (25) , or may reflect the absence of folate utilization by mature erythrocytes. We favor the latter possibility because folate uptake in other cell types is clearly related to metabolic activity (3, 23, 26) .
Uptake of 5-CH3-H4-folate by human erythrocytes increases after ATP depletion, thereby resembling Mtx uptake by rabbit reticulocytes (4) and L-1210 leukemia cells (19, 27) . However, in contrast to these experimental systems, wherein metabolic poisons apparently inhibit an energy-dependent efflux mechanism without altering influx (resulting in a net increase of uptake) (4, 19), we found efflux rate constants in control and F/CN-treated human erythrocytes were nearly identical. Other possible explanations for the consistent increase of uptake after energy depletion were also considered and excluded. For example, passive diffusion was not increased after F/CN treatment because the slope of the relationship between 5-CH3-H4-folate uptake and extracellular 5-CH3-H4-folate concentration at high levels was the same in control and energydepleted cells. Swelling of the cells after energy depletion, with a concomitant increase in surface area of membrane available for diffusion, also is not a likely cause of the observed increase in uptake; if uptake were standardized by hematocrit rather than by cell number, the increment after energy depletion remained, and mean corpuscular volume actually decreased slightly rather than increased. Therefore these studies, while showing that 5-CH3-H4-folate uptake can occur in the absence of ATP, do not provide an explanation for the enhanced uptake by energy-depleted erythrocytes.
The physiologic significance of erythrocyte folate uptake is not clear. Erythrocyte folate is largely polyglutamates of 5-CH3-H4-folate (28) , and its function, if any, is unknown. Under the conditions of these experiments, incorporated folate was not conjugated and no transfer of label to other compounds was detected. In cells actively utilizing folate, 5-CH3-H4-folate is rapidly and almost completely demethylated to tetrahydrofolate with production of methionine (29) . Significant labeling of this low molecular weight compound should have been detected in our system, but was not, suggesting little or none was formed. Therefore, although peripheral erythrocytes retain the capacity to transport folate, this newly incorporated vitamin probably does not have a major role in erythrocyte metabolism. Further investigations of' erythrocyte folate uptake seem warranted, however, because membrane transport function can be studied directly, and (Iuantities of these cells are readily available for detailed characterization of the membrane-carrier system.
